Converti Blue Pepe BLUPEPE in Transfidelity FIDEL

Once upon a meme, Base was for everyone — a place to build onchain, a canvas for creators, and a launchpad for wild ideas. It was our onchain summer, fast, based, and buzzing with life. Now Blue Pepe peeks out, not to preach, but to remind us of the magic we first felt. A wide grin, a blue glow, and a simple dream: to bring the fun back and build a truly based community. No hype. No noise. Just pure blue energy. 0x8a910eA80fC09D5b5a2120521A39B67980df0BC4 ABOUT From the deep corners of meme-land, a blue frog reappears. He’s not a savior — he’s a reminder. That the golden era of Base wasn’t about charts or words, but laughter, chaos, and the connections we built onchain. Blue Pepe just shows up, smiles, and paints the chain blue again. Because sometimes, the world doesn’t need more talk — it just needs another good laugh. Blue Pepe isn’t about numbers — but if you must know, here’s the funny part Total Supply – 1,000,000,000 $BLUPEPE Enough $BLUPEPE for every believer who still laughs. Zero Tax Because taxes kill the joke. LP Locked Forever Safe, strong, and meme-proof. Community Rules Pepe’s just the face. You’re the movement. No Dev Wallet No hidden stash. No puppeteer. Just people. Built on Base Fast, bright, and ready to be painted blue again. Why blue? Because green got boring. Blue is the future, clarity, and a bit of rebellion. Who’s it for? Who made it? Is there a roadmap? How far will this go? What’s the goal? We’re not a cult — we just like the same color. We’re not marketers — we just make each other laugh. If you smiled when you saw this frog, you’re already one of us.

Neurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates. Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia. Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progress made to stop or reverse disease. We’re trying to go after a potential root cause - rather than trying to clear aggregates once they are there, we aim to prevent them from forming in the first place by reducing the production of faulty proteins. With a clear path towards developing novel intellectual property (IP) and an ever-growing target market, we believe we are poised to make an impact on neurodegenerative disorders and the way we age.